Femasys
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Georgia, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3950 Johns Creek Ct Ste 100, Suwanee, Ge...Phone Number
(877) 336-2562Website
www.femasys.comRevenue
<$5 MillionStock Symbol
FEMYIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Femasys
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare prRead more
Femasys Org Chart
Get the full picture
Sign in to uncover key details.
UP
Quality Vice President, Regulatory
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Femasys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Femasys is spiking on competitors!
Earning: See what the market has to say on Femasys recently announced quarterly report
Product Launch: Get notified when Femasys launches new products
Website visits: Recent activity has been detected on your website
Check if Femasys has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Femasys
Femasys, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Femasys had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Femasys has new funding data
Recommended Actions
Find VP level buyers at Femasys
Find more new buyers
Compare Similar Companies to Femasys
Compare insights from companies similar to Femasys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Femasys is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Femasys is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Femasys.
Femasys financials insights
Gather financial insights about Femasys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$641K
Unspecified
$1.8M
2012
Private Equity
$1M
2015
Series B
$10.2M
2016
Private Equity
$3.3M
Series C
$40M
2020
Debt
$350K
2023
Other Financing Round
$5M
2025
Stock/Share Issuance
$10M
Stock/Share Issuance
$12M
Femasys Tech Stack
A closer look at the technologies used by Femasys
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Kathy Lee-Sepsick fertility portfolio and allows OB/GYNs to offer more in-office fertility services.
Doctors / Physicians
Person-Based
Product Launch
Executive Move
Executive Moves, Board of Directors
Femasys News & Media
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
-- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices -- -- With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices --Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
-- Integrated sperm preparation and intratubal insemination drive earlier intervention and streamlined, in-office care within routine OB/GYN practice -- ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today the first revenue-generating commercial use of its fertility portfolio in the OBGYN setting, led by FemaFemasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient access Expanding commercialization of first-line fertility treatment in the OB/GYN office to increase patient accessFemasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
-- Partnership with AMI Technologies Positions FemaSeed® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions -- ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today a strategic partnership with AMI Technologies to introduce and commercialize its fertili
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Femasys
Sign Up For FreeTo access detailed company insights
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product... Read More
